In particular, it was reported that IFN-γ may drive the upregulation of PD-L1 in cancer cells and the TME’s cells as well as stimulate more IL-12 secretion, thus activating a positive feedback loop of IFN-γ. The gene discussed is IFNG; the disease is cancer.